iShares Global Healthcare ETF
IXJ
New York Stock Exchange Arca- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- iShares Global Healthcare ETF (IXJ) seeks to track the investment results of an index composed of global equities in the healthcare sector, specifically the S&P Global 1200 Healthcare Sector Index, which includes companies classified in the Global Industry Classification Standard (GICS) healthcare sector from the S&P Global 1200. The ETF provides investors with exposure to a diversified portfolio of healthcare companies spanning pharmaceuticals, biotechnology, healthcare equipment and supplies, healthcare providers and services; top holdings include Eli Lilly and Company (8.12%), Johnson & Johnson (5.98%), AbbVie Inc. (5.17%), UnitedHealth Group Incorporated (3.87%), and AstraZeneca PLC (3.49%), with approximately 129 total holdings and a top 10 concentration of 42.03%. Managed passively by BlackRock Fund Advisors with an expense ratio of 0.40%, the fund employs a sampling approach to replicate the index's float-adjusted market-cap weighted performance, rebalanced quarterly, and distributes dividends quarterly. Launched on November 13, 2001, and listed on NYSE Arca, IXJ is issued by BlackRock, Inc., headquartered in New York, with assets under management of approximately $3.82 billion as of recent data. The ETF operates globally, with primary exposure to developed markets including the United States, Europe, and Japan, targeting institutional and retail investors seeking sector-specific equity exposure in healthcare; it does not pursue a sustainable, impact, or ESG investment strategy. In recent developments, IXJ has seen portfolio adjustments including the addition of EUR cash holdings and USD cash collateral for futures contracts as of November 26, 2025, reflecting standard operational liquidity and hedging management amid market conditions. BlackRock, the issuer, continues to innovate in its iShares lineup, exemplified by the September 2025 conversion of two Global Allocation mutual funds into active ETFs (BDYN and BDVL), signaling broader strategic evolution in ETF offerings, though IXJ remains a passive sector fund with no reported acquisitions, partnerships, or major reorganizations specific to it in the last 1-2 years.